Nippon Kayaku Co., Ltd.
Stock Price Chart
2026/07/14 UpdatedPrice Trend
2026/07/14 UpdatedPrice & Trading Details
2026/07/14 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/07/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2018/07/30 | ¥18.50 | ¥25.65 | +38.7% |
| 2017/05/09 | ¥- | ¥27.62 | - |
Shareholder Composition
Updated 2026/07/01Major Holders
Updated 2026/07/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.1M | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.3M | +1.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
994.0K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
985.6K | +0.46% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
691.5K | 0.00% | |
|
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund
|
647.8K | -9.54% |
Dividend History
Updated 2026/07/12| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥36 | -46.7% |
| 2025 | ¥68 | +50.0% |
| 2024 | ¥45 | -5.3% |
| 2023 | ¥48 | +5.6% |
| 2022 | ¥45 | - |
Financial Performance
2026/07/12 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥184,805M | ¥198,380M | ¥201,791M | ¥222,584M |
| Gross Profit | ¥63,967M | ¥66,752M | ¥61,301M | ¥71,482M |
| Operating Income | ¥21,052M | ¥21,506M | ¥7,338M | ¥20,402M |
| Pretax Income | ¥23,782M | ¥21,075M | ¥7,332M | ¥22,231M |
| Net Income | ¥17,181M | ¥14,984M | ¥4,113M | ¥17,508M |
| EPS | ¥101.65 | ¥89.33 | ¥24.79 | ¥107.16 |
| Operating Margin | 11.39% | 10.84% | 3.64% | 9.17% |
| Balance Sheet | ||||
| Total Assets | ¥315,459M | ¥322,858M | ¥363,173M | ¥373,708M |
| Total Equity | ¥245,479M | ¥254,016M | ¥269,560M | ¥267,526M |
| Total Liabilities | ¥69,980M | ¥68,842M | ¥93,613M | ¥106,182M |
| Cash | ¥38,459M | ¥48,051M | ¥56,749M | ¥55,425M |
| Interest-bearing Debt | ¥16,650M | ¥19,580M | ¥31,450M | ¥42,096M |
| Equity Ratio | 77.82% | 78.68% | 74.22% | 71.59% |
| D/E Ratio | 0.07 | 0.08 | 0.12 | 0.16 |
| Cash Flow | ||||
| Operating CF | ¥23,141M | ¥20,039M | ¥23,242M | ¥25,530M |
| Investing CF | -¥10,641M | -¥15,158M | -¥19,409M | -¥27,313M |
| Financing CF | -¥11,090M | -¥7,950M | ¥3,823M | -¥4,756M |
| Free CF | ¥13,674M | ¥7,052M | ¥7,220M | -¥5,478M |
| Efficiency | ||||
| ROE | 7.00% | 5.90% | 1.53% | 6.54% |
| ROA | 5.45% | 4.64% | 1.13% | 4.68% |
Latest IR Information
-
Notice on the Status of Share Buyback
Based on a board resolution dated May 12, 2026, we conducted a share buyback of common stock. From June 1 to June 30, 2026, the cumulative number of shares acquired through market purchases was 1,244,100 shares, with a total acquisition...
Read more -
Disposal of Treasury Stock with Transfer Restrictions | June 2026
Nippon Chemical Industries will dispose of 43,463 shares of treasury stock at 2,056.5 yen per share on July 17, 2026, raising a total of 89.38 million yen. A stock compensation system is introduced for targeted directors and executive officers to...
Read more -
【Nihon Kagaku Pharmaceutical】Share Buyback of 286,900 shares (~¥6.16 billion)｜May 2026
Nihon Kagaku Pharmaceutical resolved at its Board of Directors meeting on May 12, 2026, to acquire 286,900 shares of treasury stock through market purchases on the Tokyo Stock Exchange, at a total cost of approximately ¥6.16 billion. The acquisition period...
Read more -
【Nippon Kayaku】Manufacturing and Sales Approval Transfer Agreement Signed ｜ May 2026
Nippon Kayaku has signed a transfer agreement with AstraZeneca for the manufacturing and sales approval of "Zoladex® 3.6mg Depot / LA 10.8mg Depot," aiming to ensure stable supply and lifecycle optimization. The transfer was announced on May 12, 2026, and...
Read more -
【Nihon Kagaku Yakuhin】Receipt of Dividends from Consolidated Subsidiaries | May 2026
Nihon Kagaku Yakuhin received 8,519 million yen in dividends from its consolidated subsidiary in the fiscal year ending March 2026. The amount is recorded as non-operating income and does not impact the consolidated performance.
Read more
Latest News (5 items)
Company Information
About
Nippon Kayaku Co., Ltd. engages in mobility and imaging, fine chemicals, and life sciences businesses in Japan. The company offers airbag inflators, micro gas generators for seatbelt pretensioners and squib; and liquid crystal display (LCD) projector and display, and x-ray analysis system components. It also provides epoxy and maleimide resin, epoxy resin hardener, reactive flame retardant, acrylic acid esters, UV-curable resins for resist, resist for MEMS, cleaners for LCDs and semiconductors, and LCD sealants, as well as semiconductor manufacturing equipment, such as laminator, remover, mounter, UV irradiation equipment; colorants for inkjet printers, dyes for inkjet textile printing, inks for industrial inkjet printers, image sensor materials, dichotomous colorants for dimmable glass, near infrared absorbers, dyes for textiles and paper, colorants for resins, developers for thermal paper, and pigment derivative; and catalysts for the production of acrylic acid, acrolein, and methacrylic acid. In addition, the company offers Anti-cancer and biological drugs, cardiovascular and photodynamic diagnostic agents, in-vitro diagnostic drugs, embolization materials, pharmaceutical API and intermediates, food additives, health food ingredients, preservatives for food quality, and cleaners and disinfectants; Insecticides, herbicides, fungicides, miticides, public health insecticides, soil fumigants, and animal repellents; and engages in real estate business. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
